Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Total Current Liabilities (2017 - 2025)

Neuronetics (STIM) has disclosed Total Current Liabilities for 9 consecutive years, with $30.5 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 2.38% to $30.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.5 million through Dec 2025, down 2.38% year-over-year, with the annual reading at $30.5 million for FY2025, 2.38% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $30.5 million at Neuronetics, up from $28.9 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $47.8 million in Q3 2021, with the low at $10.9 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $22.3 million, with a median of $19.4 million recorded in 2022.
  • The sharpest move saw Total Current Liabilities tumbled 74.47% in 2021, then skyrocketed 111.42% in 2022.
  • Over 5 years, Total Current Liabilities stood at $15.7 million in 2021, then skyrocketed by 111.42% to $33.2 million in 2022, then tumbled by 40.32% to $19.8 million in 2023, then soared by 57.81% to $31.3 million in 2024, then decreased by 2.38% to $30.5 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $30.5 million, $28.9 million, and $27.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.